Bed Rest for Threatened Preterm Labor. Pilot Study

NCT ID: NCT00873314

Last Updated: 2009-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2006-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the pilot trial is to assess at what extend women with arrested threatened preterm labor change their activity patterns at home in response to bed rest prescription.

An area of concern for the design of a trial is the strength of health provider's recommendation to change women's behaviors, and their compliance with bed rest recommendations. The study was a randomized parallel design. The intervention group consisted of total bed rest for four days (with allowance to go to the toilet). The control group consisted in the restriction of activities during four days.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bedrest Premature Labor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bed rest

Group Type EXPERIMENTAL

Bed rest

Intervention Type BEHAVIORAL

The woman assigned to the bed rest group, will be instructed to keep in bed for the study period of four days and will be allowed to go to the toilet

Activity restriction

Group Type PLACEBO_COMPARATOR

Activity restriction

Intervention Type BEHAVIORAL

Women assigned to activity restriction group will do the restriction of activities during four days.During the activity restriction phase the women will be allowed to ambulate at home, work at home (home office), child care, household tasks, meal preparation or any forceless activities.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bed rest

The woman assigned to the bed rest group, will be instructed to keep in bed for the study period of four days and will be allowed to go to the toilet

Intervention Type BEHAVIORAL

Activity restriction

Women assigned to activity restriction group will do the restriction of activities during four days.During the activity restriction phase the women will be allowed to ambulate at home, work at home (home office), child care, household tasks, meal preparation or any forceless activities.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Every woman admitted to hospital during the antenatal period because of an episode of TPL. If the attending physician decides that the woman is ready for hospital discharge the woman will be eligible for the study.

Exclusion Criteria

* Multiple pregnancy
* Premature rupture of membranes
* Cervical cerclage and whenever the attendant physician considers that the woman is not eligible to be randomized to bed rest or activity restriction.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unidad de Investigación Clínica y Epidemiológica Montevideo

OTHER

Sponsor Role collaborator

Institute for Clinical Effectiveness and Health Policy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Institute for Clinical Effectiveness and Health Policy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pereira Rossell Hospital

Montevideo, , Uruguay

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Uruguay

Related Links

Access external resources that provide additional context or updates about the study.

http://www.iecs.org.ar/

Institute for Clinical Effectiveness and Health Policy

http://www.fmed.edu.uy/

School of Medicine of the University of the Republic

http://www.unicem-web.org/

Clinical and Epidemiological Research Unit Montevideo

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIHR01-2003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Decision Aid - Extreme Prematurity
NCT01713894 COMPLETED NA